Cargando…
Therapeutic effects of statins against lung adenocarcinoma via p53 mutant-mediated apoptosis
The p53 gene is an important tumour suppressor gene. Mutant p53 genes account for about half of all lung cancer cases. There is increasing evidence for the anti-tumour effects of statins via inhibition of the mevalonate pathway. We retrospectively investigated the correlation between statin use and...
Autores principales: | Chou, Cheng-Wei, Lin, Ching-Heng, Hsiao, Tzu-Hung, Lo, Chia-Chien, Hsieh, Chih-Ying, Huang, Cheng-Chung, Sher, Yuh-Pyng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938497/ https://www.ncbi.nlm.nih.gov/pubmed/31892709 http://dx.doi.org/10.1038/s41598-019-56532-6 |
Ejemplares similares
-
Identification of theranostic factors for patients developing metastasis after surgery for early-stage lung adenocarcinoma
por: Cheng, Wei-Chung, et al.
Publicado: (2021) -
Inhibition of CDCP1 by 8‐isopentenylnaringenin synergizes with EGFR inhibitors in lung cancer treatment
por: Wong, Sze‐Ching, et al.
Publicado: (2023) -
Potential Therapeutic Benefit of Combining Gefitinib and Tamoxifen for Treating Advanced Lung Adenocarcinoma
por: Liu, Chien-Ming, et al.
Publicado: (2015) -
An Overview of ADAM9: Structure, Activation, and Regulation in Human Diseases
por: Chou, Cheng-Wei, et al.
Publicado: (2020) -
Targeting positive feedback between BASP1 and EGFR as a therapeutic strategy for lung cancer progression
por: Lin, Ching-Chan, et al.
Publicado: (2020)